A Novel CMV-Specific TCR-T Cell Therapy Is Effective and Safe for Refractory CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation
- Resource Type
- Abstract
- Source
- In
Blood 23 November 2021 138 Supplement 1:3848-3848 - Subject
- Language
- ISSN
- 0006-4971